Today, Q3 2016 EPS Estimates for Acadia Healthcare Co. (ACHC) Decreased by Analyst

Today, Q3 2016 EPS Estimates for Acadia Healthcare Co. (ACHC) Decreased by Analyst

Acadia Healthcare Co. (NASDAQ:ACHC) – Analysts at KeyCorp lowered their Q3 2016 earnings estimates for Acadia Healthcare in a note issued to investors on Monday. KeyCorp analyst J. Gurda now forecasts that the brokerage will earn $0.66 per share for the quarter, down from their prior forecast of $0.68. KeyCorp also issued estimates for Acadia Healthcare’s FY2016 earnings at $2.57 EPS, FY2017 earnings at $3.06 EPS and FY2018 earnings at $3.79 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Friday, July 29th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. The company had revenue of $756.50 million for the quarter, compared to the consensus estimate of $752.57 million. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. The company’s quarterly revenue was up 66.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.57 earnings per share.

A number of other research firms have also recently issued reports on ACHC. Leerink Swann reiterated a “buy” rating and set a $80.00 target price on shares of Acadia Healthcare in a report on Sunday, August 28th. Jefferies Group restated a “buy” rating and set a $85.00 price objective on shares of Acadia Healthcare in a research note on Monday, June 27th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, October 3rd. Royal Bank Of Canada reduced their price objective on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Finally, JPMorgan Chase & Co. restated a “hold” rating and set a $61.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, September 27th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $77.21.

Acadia Healthcare (NASDAQ:ACHC) traded up 1.77% during midday trading on Tuesday, reaching $44.21. The company’s stock had a trading volume of 321,648 shares. Acadia Healthcare has a 52 week low of $42.47 and a 52 week high of $74.77. The firm has a 50 day moving average price of $49.16 and a 200-day moving average price of $54.58. The firm has a market cap of $3.86 billion, a P/E ratio of 23.62 and a beta of 0.86.

A number of large investors have recently modified their holdings of the company. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 97.2% in the first quarter. Wellington Management Group LLP now owns 6,983,799 shares of the company’s stock valued at $384,877,000 after buying an additional 3,441,579 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Acadia Healthcare by 5.3% in the second quarter. JPMorgan Chase & Co. now owns 4,999,726 shares of the company’s stock valued at $276,985,000 after buying an additional 251,179 shares during the period. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 6.0% in the second quarter. Vanguard Group Inc. now owns 4,980,554 shares of the company’s stock valued at $275,924,000 after buying an additional 283,624 shares during the period. TCW Group Inc. increased its stake in shares of Acadia Healthcare by 32.2% in the second quarter. TCW Group Inc. now owns 1,828,660 shares of the company’s stock valued at $101,308,000 after buying an additional 445,200 shares during the period. Finally, BlackRock Institutional Trust Company N.A. increased its stake in shares of Acadia Healthcare by 10.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,824,171 shares of the company’s stock valued at $101,059,000 after buying an additional 166,706 shares during the period.

In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 8,800 shares of the firm’s stock in a transaction that occurred on Monday, August 8th. The shares were sold at an average price of $52.56, for a total transaction of $462,528.00. Following the completion of the sale, the chief operating officer now directly owns 120,780 shares in the company, valued at $6,348,196.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David M. Duckworth sold 16,670 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $54.33, for a total transaction of $905,681.10. Following the sale, the chief financial officer now owns 11,688 shares of the company’s stock, valued at $635,009.04. The disclosure for this sale can be found here. Company insiders own 17.20% of the company’s stock.

About Acadia Healthcare

Related posts

Leave a Comment